Encompass Health (US:EHC) Financial Modeling Prep·2026-02-11 03:00Core Insights - Encompass Health Corporation is a leading provider of inpatient rehabilitation services in the U.S., recognized for its clinical quality and capital management, with a focus on sustainable double-digit EBITDA growth driven by demographic trends and regulatory barriers [1] Financial Performance - In Q4 2025, Encompass Health reported an adjusted EPS of $1.46, reflecting a 24.8% increase year-over-year and exceeding the Zacks Consensus Estimate by 13.2% [3] - The company's net operating revenues reached $1.5 billion, representing a 9.9% year-over-year growth, attributed to higher net revenue per discharge and an increase in discharges [3] Financial Metrics - Encompass Health has a P/E ratio of 19.29, indicating that investors are willing to pay $19.29 for every dollar of earnings [4] - The price-to-sales ratio stands at 1.85, and the enterprise value to sales ratio is 1.88, reflecting the market's valuation of the company [4] - The company maintains a low debt-to-equity ratio of 0.08, showcasing a conservative leverage approach that enhances financial resilience [4] Operational Strength - The company owns 79% of its real estate, which supports its operational leverage and efficient hospital development [5] - Encompass Health's current ratio is 1.08, indicating its capability to meet short-term liabilities [5] - The company is recognized as a strong growth stock, with Zacks Style Scores assisting investors in identifying stocks with high short-term market outperformance potential [5]